N6-甲基氨酸甲基转移酶成分KIAA1429是癌症治疗的潜在目标
Junjun Huang1, Jihua Guo1,2, Rong Jia1
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.
Biomolecules
|October 26, 2024
概括
在N6-甲基氨酸 (m6A) RNA修饰中的关键蛋白质KIAA1429,通过调节瘤相关基因来驱动癌症的进展. 准KIAA1429为新型抗癌疗法提供了一个有前途的战略.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- N6-甲基氨酸 (m6A) 是真核生物中最常见的RNA修饰,显著影响瘤发生.
- KIAA1429 作为 m6A 甲基转移酶复合体中的关键支架蛋白,桥梁催化核心组件.
- 在恶性瘤中经常观察到KIAA1429的过度表达,与患者的预后相关.
研究的目的:
- 审查了解KIAA1429在各种癌症中的作用和机制方面的最新进展.
- 探索向KIAA1429开发新的抗癌治疗策略的潜力.
主要方法:
- 关于研究KIAA1429在癌症中的功能的文献综述.
- 通过m6A修改对KIAA1429对瘤相关基因的调控影响的分析.
- 检查KIAA1429对癌症特征如扩散,迁移和转移的贡献.
主要成果:
- 过度表达KIAA1429与患者不良结果有关,对瘤发育至关重要.
- KIAA1429 调节了许多瘤相关基因的表达,以一种m6A-依赖的方式.
- 这种KIAA1429的调节促进了癌细胞的增殖,迁移,耐药性和转移.
结论:
- KIAA1429通过m6A-依赖基因调节在癌症进展中发挥着重要作用.
- 准KIAA1429为对抗各种类型癌症提供了潜在的治疗途径.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
RNA Editing
8.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


